Use of a rapid recombinase-aided amplification assay for Mycoplasma pneumoniae detection

Abstract Background Mycoplasma pneumoniae is one of the most common causative pathogens of community-acquired pneumonia (CAP), accounting for as many as 30–50% of CAP during peak years. An early and rapid diagnostic method is key for guiding clinicians in their choice of antibiotics. Methods The rec...

Full description

Bibliographic Details
Main Authors: Guanhua Xue, Shaoli Li, Hanqing Zhao, Chao Yan, Yanling Feng, Jinghua Cui, Tingting Jiang, Jing Yuan
Format: Article
Language:English
Published: BMC 2020-01-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-019-4750-4
_version_ 1819168994146385920
author Guanhua Xue
Shaoli Li
Hanqing Zhao
Chao Yan
Yanling Feng
Jinghua Cui
Tingting Jiang
Jing Yuan
author_facet Guanhua Xue
Shaoli Li
Hanqing Zhao
Chao Yan
Yanling Feng
Jinghua Cui
Tingting Jiang
Jing Yuan
author_sort Guanhua Xue
collection DOAJ
description Abstract Background Mycoplasma pneumoniae is one of the most common causative pathogens of community-acquired pneumonia (CAP), accounting for as many as 30–50% of CAP during peak years. An early and rapid diagnostic method is key for guiding clinicians in their choice of antibiotics. Methods The recombinase-aided amplification (RAA) assay is a recently developed, rapid detection method that has been used for the detection of several pathogens. The assays were performed in a one-step single tube reaction at 39° Celsius within 15–30 min. In this study, we established an RAA assay for M. pneumoniae using clinical specimens for validation and commercial real-time PCR as the reference method. Results The analytical sensitivity of the RAA assay was 2.23 copies per reaction, and no cross-reactions with any of the other 15 related respiratory bacterial pathogens were observed. Compared with the commercial real-time PCR assay used when testing 311 respiratory specimens, the RAA assay obtained 100% sensitivity and 100% specificity with a kappa value of 1. Conclusions These results demonstrate that the proposed RAA assay will be of benefit as a faster, sensitive, and specific alternative tool for the detection of M. pneumoniae.
first_indexed 2024-12-22T19:12:26Z
format Article
id doaj.art-190add129595473bab5b8bfd4d7ef261
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-22T19:12:26Z
publishDate 2020-01-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-190add129595473bab5b8bfd4d7ef2612022-12-21T18:15:38ZengBMCBMC Infectious Diseases1471-23342020-01-012011710.1186/s12879-019-4750-4Use of a rapid recombinase-aided amplification assay for Mycoplasma pneumoniae detectionGuanhua Xue0Shaoli Li1Hanqing Zhao2Chao Yan3Yanling Feng4Jinghua Cui5Tingting Jiang6Jing Yuan7Department of Bacteriology, Capital Institute of PediatricsDepartment of Bacteriology, Capital Institute of PediatricsDepartment of Bacteriology, Capital Institute of PediatricsDepartment of Bacteriology, Capital Institute of PediatricsDepartment of Bacteriology, Capital Institute of PediatricsDepartment of Bacteriology, Capital Institute of PediatricsDepartment of Obstetrics, Southern District of the Fifth Medical Center of PLA General HospitalDepartment of Bacteriology, Capital Institute of PediatricsAbstract Background Mycoplasma pneumoniae is one of the most common causative pathogens of community-acquired pneumonia (CAP), accounting for as many as 30–50% of CAP during peak years. An early and rapid diagnostic method is key for guiding clinicians in their choice of antibiotics. Methods The recombinase-aided amplification (RAA) assay is a recently developed, rapid detection method that has been used for the detection of several pathogens. The assays were performed in a one-step single tube reaction at 39° Celsius within 15–30 min. In this study, we established an RAA assay for M. pneumoniae using clinical specimens for validation and commercial real-time PCR as the reference method. Results The analytical sensitivity of the RAA assay was 2.23 copies per reaction, and no cross-reactions with any of the other 15 related respiratory bacterial pathogens were observed. Compared with the commercial real-time PCR assay used when testing 311 respiratory specimens, the RAA assay obtained 100% sensitivity and 100% specificity with a kappa value of 1. Conclusions These results demonstrate that the proposed RAA assay will be of benefit as a faster, sensitive, and specific alternative tool for the detection of M. pneumoniae.https://doi.org/10.1186/s12879-019-4750-4Mycoplasma pneumoniaeRecombinaseRecombinase-aided amplificationDetectionMolecular diagnostic technique
spellingShingle Guanhua Xue
Shaoli Li
Hanqing Zhao
Chao Yan
Yanling Feng
Jinghua Cui
Tingting Jiang
Jing Yuan
Use of a rapid recombinase-aided amplification assay for Mycoplasma pneumoniae detection
BMC Infectious Diseases
Mycoplasma pneumoniae
Recombinase
Recombinase-aided amplification
Detection
Molecular diagnostic technique
title Use of a rapid recombinase-aided amplification assay for Mycoplasma pneumoniae detection
title_full Use of a rapid recombinase-aided amplification assay for Mycoplasma pneumoniae detection
title_fullStr Use of a rapid recombinase-aided amplification assay for Mycoplasma pneumoniae detection
title_full_unstemmed Use of a rapid recombinase-aided amplification assay for Mycoplasma pneumoniae detection
title_short Use of a rapid recombinase-aided amplification assay for Mycoplasma pneumoniae detection
title_sort use of a rapid recombinase aided amplification assay for mycoplasma pneumoniae detection
topic Mycoplasma pneumoniae
Recombinase
Recombinase-aided amplification
Detection
Molecular diagnostic technique
url https://doi.org/10.1186/s12879-019-4750-4
work_keys_str_mv AT guanhuaxue useofarapidrecombinaseaidedamplificationassayformycoplasmapneumoniaedetection
AT shaolili useofarapidrecombinaseaidedamplificationassayformycoplasmapneumoniaedetection
AT hanqingzhao useofarapidrecombinaseaidedamplificationassayformycoplasmapneumoniaedetection
AT chaoyan useofarapidrecombinaseaidedamplificationassayformycoplasmapneumoniaedetection
AT yanlingfeng useofarapidrecombinaseaidedamplificationassayformycoplasmapneumoniaedetection
AT jinghuacui useofarapidrecombinaseaidedamplificationassayformycoplasmapneumoniaedetection
AT tingtingjiang useofarapidrecombinaseaidedamplificationassayformycoplasmapneumoniaedetection
AT jingyuan useofarapidrecombinaseaidedamplificationassayformycoplasmapneumoniaedetection